Page last updated: 2024-09-05

varenicline and Cognition Disorders

varenicline has been researched along with Cognition Disorders in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, RC; Chu, JM; Huang, C; Liu, Y; Wong, GT1
Becker, C; Bencherif, M; Kucinski, A; Lippiello, P; Stachowiak, EK; Stachowiak, MK; Wersinger, S1
D'Souza, G; Kim, D; McGregor, AL; Tingle, MD1
Herman, AI; Mooney, M; Sofuoglu, M; Waters, AJ1
Cho, DM; Jung, DU; Jung, SS; Kang, JW; Kelly, DL; Kim, SD; Kong, BG; Lee, JH; Lee, SW; McMahon, RP; Oh, MK; Seo, YS; Shim, JC1
Garg, PK; Garg, S; Gould, RW; Nader, MA1
Cerimele, JM; Durango, A1
Freedman, R1

Reviews

1 review(s) available for varenicline and Cognition Disorders

ArticleYear
Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies.
    The Journal of clinical psychiatry, 2012, Volume: 73, Issue:8

    Topics: Adverse Drug Reaction Reporting Systems; Attention; Benzazepines; Cognition Disorders; Disease Progression; Dose-Response Relationship, Drug; Humans; Nicotinic Agonists; Psychiatric Status Rating Scales; Psychoses, Substance-Induced; Quinoxalines; Risk Factors; Schizophrenia; Schizophrenic Psychology; Smoking Cessation; Treatment Outcome; Varenicline

2012

Trials

2 trial(s) available for varenicline and Cognition Disorders

ArticleYear
Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.
    Psychopharmacology, 2009, Volume: 207, Issue:1

    Topics: Adult; Affect; Benzazepines; Blood Pressure; Cognition Disorders; Cotinine; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Neuropsychological Tests; Nicotine; Nicotinic Agonists; Quinoxalines; Severity of Illness Index; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2009
Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:3

    Topics: Adult; Antipsychotic Agents; Benzazepines; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Nicotinic Agonists; Quinoxalines; Schizophrenia; Smoking; Smoking Cessation; Treatment Outcome; Varenicline

2012

Other Studies

5 other study(ies) available for varenicline and Cognition Disorders

ArticleYear
Varenicline reduces DNA damage, tau mislocalization and post surgical cognitive impairment in aged mice.
    Neuropharmacology, 2018, Volume: 143

    Topics: Aging; Animals; Apoptosis; Cognition Disorders; DNA Damage; Hippocampus; Inflammation; Laparotomy; Male; Mice, Inbred C57BL; Neuroglia; Neurons; Nootropic Agents; Postoperative Complications; Random Allocation; tau Proteins; Varenicline

2018
The effects of varenicline on sensory gating and exploratory behavior with pretreatment with nicotinic or 5-HT3A receptor antagonists.
    Behavioural pharmacology, 2015, Volume: 26, Issue:1-2

    Topics: Animals; Benzazepines; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Nicotinic Agonists; Quinoxalines; Receptors, Serotonin, 5-HT3; Reflex, Startle; Schizophrenia; Sensory Gating; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists; Varenicline

2015
Varenicline improves motor and cognitive deficits and decreases depressive-like behaviour in late-stage YAC128 mice.
    Neuropharmacology, 2017, Volume: 116

    Topics: Animals; Anxiety; Cell Proliferation; Cognition Disorders; Corpus Striatum; Depression; Disease Models, Animal; Female; Hippocampus; Huntington Disease; Male; Maze Learning; Memory; Mice, Transgenic; Motor Activity; Movement Disorders; Neural Stem Cells; Neuroprotective Agents; Nicotinic Agonists; Varenicline

2017
Effects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history.
    Neuropharmacology, 2013, Volume: 64

    Topics: Animals; Behavior, Animal; Benzamides; Benzazepines; Bridged Bicyclo Compounds; Cocaine; Cocaine-Related Disorders; Cognition Disorders; Dopamine Uptake Inhibitors; Hippocampus; Learning; Ligands; Macaca mulatta; Male; Memory, Short-Term; Nerve Tissue Proteins; Neurons; Nicotine; Nicotinic Agonists; Nootropic Agents; Quinoxalines; Receptors, Nicotinic; Reversal Learning; Self Administration; Varenicline

2013
Exacerbation of schizophrenia by varenicline.
    The American journal of psychiatry, 2007, Volume: 164, Issue:8

    Topics: Acute Disease; Benzazepines; Cognition Disorders; Comorbidity; Female; Humans; Middle Aged; Nicotine; Quinoxalines; Recurrence; Schizophrenia; Schizophrenic Psychology; Self Medication; Smoking; Smoking Cessation; Varenicline

2007